Related references
Note: Only part of the references are listed.An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma
Yifei Dai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma
Jun Han et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma
Jing Liao et al.
HEPATOLOGY INTERNATIONAL (2020)
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
Zedong Li et al.
CANCER MEDICINE (2020)
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Jeong Il Yu et al.
CANCERS (2020)
Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
Qinjunjie Chen et al.
FRONTIERS IN ONCOLOGY (2020)
The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma
Lucas Trevisan Franca de Lima et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Opportunistic screening and survival prediction of digestive cancers by the combination of bloodmSEPT9with protein markers
Lele Song et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
Jie-ying Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine 1
James V. McCann et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma
Jiang Chen et al.
CELL DEATH & DISEASE (2019)
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shabnam Shalapour et al.
IMMUNITY (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma
Chandan Sanghera et al.
LIVER INTERNATIONAL (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors
Arun Asif et al.
PURINERGIC SIGNALLING (2019)
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
Praneeth R. Kuninty et al.
SCIENCE ADVANCES (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker
Ling Lu et al.
MOLECULAR ONCOLOGY (2019)
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice
Edoardo G. Giannini et al.
CANCERS (2019)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
David Tamborero et al.
CLINICAL CANCER RESEARCH (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis
Alaa Zare et al.
CANCERS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Selection on the Major Color Gene Melanocortin-1-Receptor Shaped the Evolution of the Melanocortin System Genes
Linda Dib et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
MEP1A Contributes to Tumor Progression and Predicts Poor Clinical Outcome in Human Hepatocellular Carcinoma
Han-Yue OuYang et al.
HEPATOLOGY (2016)
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
Benedicte Delire et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
Lu Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
New immunotherapies targeting the PD-1 pathway
Jordan M. Chinai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
Noah Simon et al.
Journal of Statistical Software (2015)
Brain tumor stem cells: Molecular characteristics and their impact on therapy
David L. Schonberg et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Notch signalling beyond liver development: Emerging concepts in liver repair and oncogenesis
Carola Maria Morell et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer
Gianluigi Mazzoccoli et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Multidrug resistance associated proteins in multidrug resistance
Kamlesh Sodani et al.
CHINESE JOURNAL OF CANCER (2012)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting
Zhi Huang et al.
PROTEIN & CELL (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
P53 gene in treatment of hepatic carcinoma:: Status quo
Yong-Song Guan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC
DF Calvisi et al.
GASTROENTEROLOGY (2006)
Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma
S Mitra-Kaushik et al.
BLOOD (2004)
Suppression of lymphoma and epithelial malignancies effected by interferon γ
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
